PET/MR:Techniques, Indications and Applications

Size: px
Start display at page:

Download "PET/MR:Techniques, Indications and Applications"

Transcription

1 PET/MR:Techniques, Indications and Applications Franz Wolfgang Hirsch Professor and Head of the Department of Pediatric Radiology University Hospital Leipzig / Germany Children s Hospital University Leipzig

2 Structure and Function Need of Image Fusion? Hardware Fusion Software Fusion PET/CT SPECT/CT PET/MR PET/MR for the rest of us? Medical Inovation of the Year (2000) Niche Product (2004) Innovation for Children? (2010) Baum K.G. et al :Algorithm Generated Schemes for PET/MR Image Fusion J Digit Imaging (2011)

3 PET-MR in Children? 1. Why PET/MR? 2. How does PET/MR work? 3. Why children? 4. Application 5. Own examples 6. Trouble Hirsch FW et al.: PET/MR in children. Initial clinical experience in paediatric oncology using an integrated PET/MR scanner. Pediatr Radiol Jul;43(7):

4 Why PET/MR? Single modalities can only see a part of the whole Morphology Physiology Biochemistry MR anatomy, flow, perfusion, diffusion, function PET perfusion, function Quelle: Siemens PET/MR complementary methods

5 PET/MR Concepts Tandem vs. Integration MR PET MR / PET Tandem PET / MR Integrated PET / MR + Easier to avoid interferences - No simultaneous registration - Longer examination time + Simultaneous MR and PET + Best image coregistration + Higher throughput Source: Siemens

6 Attenuation Correction T1 out-of-phase T1 in-phase Fat image Water image µ-map Attenuation correction for PET DIXON-Sequence! Eiber, M. et al., Value of a Dixon-based MR/PET attenuation correction sequence for the localization and evaluation of PET-positive lesions Eur J Nucl Med Mol Imaging 38 (9), 2011

7 Problem with Attenuation Correction T1 out-of-phase T1 in-phase Fat image Water image µ-map Small pulmonary nodules are not well recognized in Dixon sequence Schäfer JF et al: Simultaneous whole-body PET/MR imaging in comparison to PET/CT in pediatric oncology: initial results. Radiology 2014

8 Problem with Attenuation Correction Small pulmonary nodules are PET negative 7 years old girl with rhabdomyosarcoma

9 Significantly lower radiation exposure (compared with PET-CT) Why Children? Chawla SC et al: Estimated cumulative radiation dose from PET/CT in children with malignancies: a 5-year retrospective review. Pediatr Radiol May PET/CT : 24.8 msv Radiation exposure PET: 4.6 msv (3 msv)

10 Demands Application 1. No diagnostic loss compared to conventional MR studies 2. Acceptable time (45min) 3. Not only additive benefit but symbiotic value" of the two modalities Practical realization Limitation of number and duration of the sequences Field strength of 3.0 T is used for time reduction

11 MR Sequences optional DIXON PET (AC) PET PET PET PET PET MDS = Move during scan technicque Dixon (AC) TIRM cor TIRM cor respiratorytriggered TIRM cor respiratorytriggered TIRM cor TIRM cor TIRM cor TIRM tra TIRM tra respiratorytriggered TIRM tra respiratorytriggered TIRM tra TIRM tra TIRM tra DWI tra DWI tra DWI tra DWI tra DWI tra DWI tra FLAIR, T2 T1KM respiratory-triggered T2-TSE tra, cor T2 TSE FS tra VIBE dynamic CE T1FLASH 2D FS tra CE T1FLASH 2D FS tra CE T1 SE FS CE T1 SE FS CE PET TIRM + PET 18 FDG-PET TIRM cor TIRM tra DWI tra T1 SE FS CE

12 Radionuclides and Tracers

13 90% 18 FDG PET Radionuclides 5 % 11 and C Methionin Tracers PET Visualization of glucose transport and glucose uptake Visualization of protein synthesis / diagnostic of low grade glioma Fluorin Desoxy glucose 2% 68 Ga DOTATOC Somatostatin receptor imaging: Neuroendocrine tumors, meningioma

14 90% 18 FDG PET Visualization of glucose transport and glucose uptake 5 % 11 C Methionin PET Visualization of protein synthesis / diagnostic of low grade glioma 2% 68 Ga DOTATOC Somatostatin receptor imaging: Neuroendocrine tumors, meningioma

15 90% 18 FDG PET Visualization of glucose transport and glucose uptake 5 % 11 C Methionin PET Visualization of protein synthesis / diagnostic of low grade glioma Fluorin Desoxy Glucose 3% 18 F-DOPA PET higher sensitivity than 123I-MIBG Scintigraphy in neuroblastoma 2% 68 Ga DOTATOC Somatostatin receptor imaging: Neuroendocrine tumors, meningioma Dihydroxyphenylalanine

16 PET/MR Indications 1. Oncological diseases with disseminated tumor spread staging 2. Treatment response restaging 3. Therapy planning biopsy - surgery Testicular tumor with retroperitoneal metastases Supraclavicular lymph nodes and a liver metastasis 14 years MR PET/MR PET

17 Staging: Burkitt lymphoma cervical, 2.5 year old boy The MR finding of the left-sided lymph nodes is not pathological (lymph node size left <1.5 cm) In PET +++ Lymph nodes involvement on both sides In 10% of our patients with lymphomas it comes to an upstaging after PET-MR.

18 Restaging : Acute myloid leucemia, extranodal involvement Residual tumor or scar? 15 year old girl 06 th May 07 th June 08 th August No complete remission: surgery

19 Staging: Mixed neuroblastoma / ganglioblastoma - 1 year old boy - Originated from sympathetic trunk - Inhomogeneous FDG uptake: highly differentiated tumor tissue

20 Fluoro dihydroxy phenyl alanine 18 F-FDOPA PET in neurobalstoma demonstrated a higher sensitivity than 123I-MIBG scintigraphy Meng-Yao Lu* J Characterization of Neuroblastic Tumors Using 18F-FDOPA PET Nucl Med 2013; 54:42 49

21 18 F-FDOPA PET in neurobalstoma demonstrated a higher sensitivity than 123I-MIBG scintigraphy Meng-Yao Lu* J Characterization of Neuroblastic Tumors Using 18F-FDOPA PET Nucl Med 2013; 54:42 49

22 Examples Head and Brain

23 Patient Zimmermann, Rudi, geb Refractory epilepsy without MR lesion 18 FDG-PET 6 year old girl Usfull only in patients with missing MR lesions 18 FDG-PET Interictal hypoperfusion / hypometabolism around of focus

24 65 Ga DOTATOC-PET meningioma of the optic nerve Retroorbital mass 7 year old boy 65 Ga DOTATOC-PET 65 Ga DOTATOC-PET

25 11 C-methionine-PET in multifocal brain tumor: Hot spot biopsy 11 C-methionine-PET 11 C-methionine-PET 11 C-methionine-PET

26 11 C-methionine-PET Hot spot biopsy Anaplastic astrocytoma grade III

27 Summary PET/MR in Children 1 instead of 2 studies High soft tissue contrast by MR +functional information by PET Simultaneous data acquisition Faster than sequential studies and more comfortable for patient More detailed information on nature and distribution of lesions Most accurate spatial allocation (hot spot biopsy / surgery) Important for Children Significantly lower radiation exposure than PET / CT

28 Thank you for your attention! Pet- Special thanks to MR Dr. Ina Sorge, MD, Paediatric Radiology Dr. Regine Kluge, MD PhD Nuclear medicine Dr. D. Wolf, Siemens AG Dr. H. Christiansen, MD, PhD, Paediatric oncology Berlin / Germany

PET-MRI in malignant bone tumours. Lars Stegger Department of Nuclear Medicine University Hospital Münster, Germany

PET-MRI in malignant bone tumours. Lars Stegger Department of Nuclear Medicine University Hospital Münster, Germany PET-MRI in malignant bone tumours Lars Stegger Department of Nuclear Medicine University Hospital Münster, Germany Content From PET to PET/MRI General considerations Bone metastases Primary bone tumours

More information

Bone PET/MRI : Diagnostic yield in bone metastases and malignant primitive bone tumors

Bone PET/MRI : Diagnostic yield in bone metastases and malignant primitive bone tumors Bone PET/MRI : Diagnostic yield in bone metastases and malignant primitive bone tumors Lars Stegger, Benjamin Noto Department of Nuclear Medicine University Hospital Münster, Germany Content From PET to

More information

Dr Sneha Shah Tata Memorial Hospital, Mumbai.

Dr Sneha Shah Tata Memorial Hospital, Mumbai. Dr Sneha Shah Tata Memorial Hospital, Mumbai. Topics covered Lymphomas including Burkitts Pediatric solid tumors (non CNS) Musculoskeletal Ewings & osteosarcoma. Neuroblastomas Nasopharyngeal carcinomas

More information

Optimized. clinical pathway. propels high utilization of PET/MR at Pitié-Salpêtrière Hospital

Optimized. clinical pathway. propels high utilization of PET/MR at Pitié-Salpêtrière Hospital Optimized propels high utilization of PET/MR at Pitié-Salpêtrière Hospital clinical pathway As one of Europe s largest teaching hospitals, Pitié-Salpêtrière Hospital is renowned for its innovative research

More information

MRI-PET: Oncologic Applications

MRI-PET: Oncologic Applications MRI-PET: Oncologic Applications Pablo R. Ros, MD University Hospitals Case Medical Center Case Western Reserve University SCBT-MR Boston, MA October, 2012 Pablo.Ros@UHhospitals.org Acknowledgement Osman

More information

Introduction Pediatric malignancies Changing trends & Radiation burden Radiation exposure from PET/CT Image gently PET & CT modification - PET/CT

Introduction Pediatric malignancies Changing trends & Radiation burden Radiation exposure from PET/CT Image gently PET & CT modification - PET/CT Introduction Pediatric malignancies Changing trends & Radiation burden Radiation exposure from PET/CT Image gently PET & CT modification - PET/CT protocols Tips Leukaemia / lymphoma: ~ 35% acute lymphoblastic

More information

Los Angeles Radiological Society 62 nd Annual Midwinter Radiology Conference January 31, 2010

Los Angeles Radiological Society 62 nd Annual Midwinter Radiology Conference January 31, 2010 Los Angeles Radiological Society 62 nd Annual Midwinter Radiology Conference January 31, 2010 Self Assessment Module on Nuclear Medicine and PET/CT Case Review FDG PET/CT IN LYMPHOMA AND MELANOMA Submitted

More information

Case Reports: Tumor Detection by Diffusion-Weighted MRI and ADC-Mapping with Correlation to PET/CT Results

Case Reports: Tumor Detection by Diffusion-Weighted MRI and ADC-Mapping with Correlation to PET/CT Results Case Reports: Tumor Detection by Diffusion-Weighted MRI and ADC-Mapping with Correlation to PET/CT Results Matthias Philipp Lichy, M.D.; Philip Aschoff, M.D.; Christina Pfannenberg, M.D.; Schlemmer Heinz-Peter,

More information

Hybrid systems in Medical Imaging

Hybrid systems in Medical Imaging Hybrid systems in Medical Imaging from PET/CT to PET/MR Osman Ratib, MD, PhD, FAHA Professor and chair Department of Medical Imaging and Information Sciences Head of division of Nuclear Medicine University

More information

8/10/2016. PET/CT for Tumor Response. Staging and restaging Early treatment response evaluation Guiding biopsy

8/10/2016. PET/CT for Tumor Response. Staging and restaging Early treatment response evaluation Guiding biopsy PET/CT for Tumor Response Evaluation August 4, 2016 Wei Lu, PhD Department of Medical Physics www.mskcc.org Department of Radiation Oncology www.umaryland.edu FDG PET/CT for Cancer Imaging Staging and

More information

Nuclear medicine in oncology. 1. Diagnosis 2. Therapy

Nuclear medicine in oncology. 1. Diagnosis 2. Therapy Nuclear medicine in oncology 1. Diagnosis 2. Therapy Diagnosis - Conventional methods - Nonspecific radiopharmaceuticals cumulating in tumours - Specific radiopharmaceuticals (receptor- and immunoscintigraphy)

More information

PET IMAGING (POSITRON EMISSION TOMOGRAPY) FACT SHEET

PET IMAGING (POSITRON EMISSION TOMOGRAPY) FACT SHEET Positron Emission Tomography (PET) When calling Anthem (1-800-533-1120) or using the Point of Care authorization system for a Health Service Review, the following clinical information may be needed to

More information

POSITRON EMISSION TOMOGRAPHY (PET)

POSITRON EMISSION TOMOGRAPHY (PET) Status Active Medical and Behavioral Health Policy Section: Radiology Policy Number: V-27 Effective Date: 08/27/2014 Blue Cross and Blue Shield of Minnesota medical policies do not imply that members should

More information

The Proper Use of PET/CT in Tumoring Imaging

The Proper Use of PET/CT in Tumoring Imaging The Proper Use of PET/CT in Tumoring Imaging Mijin Yun, M.D. Jong Doo Lee, M.D. Department of Radiology / Division of Nuclear Medicine Yonsei University College of Medicine, Severance Hospital E mail :

More information

PSMA PET SCANNING AND THERANOSTICS IN PROSTATE CANCER KEVIN TRACEY, MD, FRCPC PRECISION DIAGNSOTIC IMAGING REGIONAL PET/CT CENTRE

PSMA PET SCANNING AND THERANOSTICS IN PROSTATE CANCER KEVIN TRACEY, MD, FRCPC PRECISION DIAGNSOTIC IMAGING REGIONAL PET/CT CENTRE PSMA PET SCANNING AND THERANOSTICS IN PROSTATE CANCER KEVIN TRACEY, MD, FRCPC PRECISION DIAGNSOTIC IMAGING REGIONAL PET/CT CENTRE DISCLOSURES/CONFLICTS NONE OBJECTIVES Understand current diagnostic role

More information

Page: 1 of 29. For this policy, PET scanning is discussed for the following 4 applications in oncology:

Page: 1 of 29. For this policy, PET scanning is discussed for the following 4 applications in oncology: Emission Tomography Scanning Page: 1 of 29 Last Review Status/Date: June 2015 Description Positron emission tomography (PET) scans are based on the use of positron-emitting radionuclide tracers coupled

More information

Radionuclide detection of sentinel lymph node

Radionuclide detection of sentinel lymph node Radionuclide detection of sentinel lymph node Sophia I. Koukouraki Assoc. Professor Department of Nuclear Medicine Medicine School, University of Crete 1 BACKGROUND The prognosis of malignant disease is

More information

Oncologic Applications of PET Scanning

Oncologic Applications of PET Scanning 6.01.26 Oncologic Applications of PET Scanning Section 6.0 Radiology Subsection Effective Date February 15, 2015 Original Policy Date January 26, 2009 Next Review Date December 2015 Description Positron

More information

Nuclear Medicine in Oncology

Nuclear Medicine in Oncology Radiopharmaceuticals Nuclear Medicine in Oncology Practice Pharmaceutical Radionuc lide Function Tumor type Diphosphonates Tc-99m Osteoblast Bone tumor & metast. Ga-citrate Ga-67 Fe-analogue Bronchogenous

More information

PET CT for Staging Lung Cancer

PET CT for Staging Lung Cancer PET CT for Staging Lung Cancer Rohit Kochhar Consultant Radiologist Disclosures Neither I nor my immediate family members have financial relationships with commercial organizations that may have a direct

More information

PET Scan in Practice for CHI

PET Scan in Practice for CHI PET Scan in Practice for CHI - Basics, strength and weakness - Oliver Blankenstein Institute for Experimental Paediatric Endocrinology Charité-Universitätsmedizin Berlin U N I V E R S I T Ä T S M E D I

More information

Emerging Referral Patterns for Whole-Body Diffusion Weighted Imaging (WB-DWI) in an Oncology Center

Emerging Referral Patterns for Whole-Body Diffusion Weighted Imaging (WB-DWI) in an Oncology Center Emerging Referral Patterns for Whole-Body Diffusion Weighted Imaging (WB-DWI) in an Oncology Center Poster No.: C-1296 Congress: ECR 2014 Type: Scientific Exhibit Authors: G. Petralia 1, G. Conte 1, S.

More information

2004 SNM Mid-Winter Educational Symposium

2004 SNM Mid-Winter Educational Symposium 1 2 20 Numeric values 15 10 5 0 SUV corr hs 18FDG Slope corr hs SUV corr hs Slope corr hs 11C-methionin 3 11C-methionine Grading and delineation of brain tumors Differentiation of malignant from benign

More information

ROLE OF PET-CT SCAN IN LOCALLY ADVANCED HEAD & NECK CANCER: A Prospective Study

ROLE OF PET-CT SCAN IN LOCALLY ADVANCED HEAD & NECK CANCER: A Prospective Study Official publication of Orofacial Chronicle,India www.jhnps.weebly.com ORIGINAL ARTICLE ROLE OF PET-CT SCAN IN LOCALLY ADVANCED HEAD & NECK CANCER: A Prospective Study ABSTRACT: Akheel Mohammad 1, Anuj

More information

Principles of nuclear metabolic imaging. Prof. Dr. Alex Maes AZ Groeninge Kortrijk and KULeuven Belgium

Principles of nuclear metabolic imaging. Prof. Dr. Alex Maes AZ Groeninge Kortrijk and KULeuven Belgium Principles of nuclear metabolic imaging Prof. Dr. Alex Maes AZ Groeninge Kortrijk and KULeuven Belgium I. Molecular imaging probes A. Introduction - Chemical disturbances will precede anatomical abnormalities

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association PET Scanning: Oncologic Applications Page 1 of 88 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Positron Emission Tomography (PET) Scanning: Oncologic Applications

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association PET Scanning: Oncologic Applications Page 1 of 42 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: See also: Positron Emission Tomography (PET) Scanning: Oncologic

More information

PET/CT Frequently Asked Questions

PET/CT Frequently Asked Questions PET/CT Frequently Asked Questions General Q: Is FDG PET specific for cancer? A: No, it is a marker of metabolism. In general, any disease that causes increased metabolism can result in increased FDG uptake

More information

SELF-ASSESSMENT MODULE REFERENCE SPR 2018 Oncologic Imaging Course Adrenal Tumors November 10, :00 12:10 p.m.

SELF-ASSESSMENT MODULE REFERENCE SPR 2018 Oncologic Imaging Course Adrenal Tumors November 10, :00 12:10 p.m. SELF-ASSESSMENT MODULE REFERENCE SPR 2018 Oncologic Imaging Course Adrenal Tumors November 10, 2018 10:00 12:10 p.m. Staging Susan E. Sharp, MD 1. In the International Neuroblastoma Risk Group Staging

More information

FieldStrength. Leuven research is finetuning. whole body staging

FieldStrength. Leuven research is finetuning. whole body staging FieldStrength Publication for the Philips MRI Community Issue 40 May 2010 Leuven research is finetuning 3.0T DWIBS for whole body staging The University Hospital of Leuven is researching 3.0T whole body

More information

Molecular Imaging and Cancer

Molecular Imaging and Cancer Molecular Imaging and Cancer Cancer causes one in every four deaths in the United States, second only to heart disease. According to the U.S. Department of Health and Human Services, more than 512,000

More information

PET/CT and PET/MR of Cardiac Tumors

PET/CT and PET/MR of Cardiac Tumors PET/CT and PET/MR of Cardiac Tumors Andrew W. Bowman, MD PhD Assistant Professor of Radiology Mayo Clinic Florida NASCI Annual Meeting San Antonio, TX Oct 9, 2017 2017 MFMER slide-1 Disclosures No financial

More information

Colorectal Cancer and FDG PET/CT

Colorectal Cancer and FDG PET/CT Hybrid imaging in colorectal & esophageal cancer Emmanuel Deshayes IAEA WorkShop, November 2017 Colorectal Cancer and FDG PET/CT 1 Clinical background Cancer of the colon and rectum is one of the most

More information

Nuclear Medicine and PET. D. J. McMahon rev cewood

Nuclear Medicine and PET. D. J. McMahon rev cewood Nuclear Medicine and PET D. J. McMahon 150504 rev cewood 2018-02-15 Key Points Nuclear Medicine and PET: Imaging: Understand how Nuc Med & PET differ from Radiography & CT by the source of radiation. Be

More information

Nuclear Medicine in the Diabetic Foot

Nuclear Medicine in the Diabetic Foot 26.11.2015, Uniklinik Balgrist Nuclear Medicine in the Diabetic Foot Martin Hüllner Nuklearmedizin und Neuroradiologie, USZ / UZH Outline A. Imaging modalities brief technical overview B. Nuclear medicine

More information

Whole Body MRI. Dr. Nina Tunariu. Prostate Cancer recurrence, progression and restaging

Whole Body MRI. Dr. Nina Tunariu. Prostate Cancer recurrence, progression and restaging Whole Body MRI Prostate Cancer recurrence, progression and restaging Dr. Nina Tunariu Consultant Radiology Drug Development Unit and Prostate Targeted Therapies Group 12-13 Janeiro 2018 Evolving Treatment

More information

PET/CT in lung cancer

PET/CT in lung cancer PET/CT in lung cancer Andrei Šamarin North Estonia Medical Centre 3 rd Baltic Congress of Radiology 08.10.2010 Imaging in lung cancer Why do we need PET/CT? CT is routine imaging modality for staging of

More information

Index. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.

Index. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type. Surg Oncol Clin N Am 16 (2007) 465 469 Index Note: Page numbers of article titles are in boldface type. A Adjuvant therapy, preoperative for gastric cancer, staging and, 339 B Breast cancer, metabolic

More information

Nuclear Medicine: Basics to therapy

Nuclear Medicine: Basics to therapy Nuclear Medicine: Basics to therapy RCP Medical careers day Dr Sabina Dizdarevic MD MSc PhD FRCP Dr Deena Neriman MBBS FRCR Ms Charlotte Weston CEO BNMS On behalf of the British Nuclear Medicine Society

More information

PET-CT for radiotherapy planning in lung cancer: current recommendations and future directions

PET-CT for radiotherapy planning in lung cancer: current recommendations and future directions PET-CT for radiotherapy planning in lung cancer: current recommendations and future directions Gerry Hanna Centre for Cancer Research and Cell Biology Queen s University of Belfast @gerryhanna Talk Outline

More information

Chapter 10. Summary, conclusions and future perspectives

Chapter 10. Summary, conclusions and future perspectives Chapter 10 Summary, conclusions and future perspectives 10.1 SUMMARY In this thesis, a new tumor imaging tracer in nuclear medicine is studied. This 123 tracer, L-3-[ I]Iodo-alpha-methyl-tyrosine (IMT),

More information

Quantitative Nuclear Medicine Imaging in Oncology. Susan E. Sharp, MD

Quantitative Nuclear Medicine Imaging in Oncology. Susan E. Sharp, MD Quantitative Nuclear Medicine Imaging in Oncology Susan E. Sharp, MD Disclosures None Objectives Describe scoring systems used in oncologic nuclear medicine imaging Deauville scoring in lymphoma Curie

More information

Nuclear Sciences and Medicine

Nuclear Sciences and Medicine Nuclear Sciences and Medicine Rethy Chhem, MD, PhD (Edu), PhD (His), FRCPC Division of Human Health Guest Professor, Medical University of Vienna International Atomic Energy Agency Medical Imaging X-rays

More information

What Radiologists do?

What Radiologists do? Multimodality Imaging in Oncology 2018 March 5 th 9th Diagnostic Imaging in Oncology What Radiologists do? Chikako Suzuki, MD, PhD Department of Diagnostic Radiology, KS Solna Department of Molecular Medicine

More information

Indications of PET/CT in oncology

Indications of PET/CT in oncology Monday, August 27, 2012 Session 1, 10:00-10:40 Indications of PET/CT in oncology Helle Westergren Hendel MD, PhD, assistant professor Bacelor in Leadership & Health Ecomomics Head of Clinical PET, Herlev

More information

PET/CT in oncology. Positron emission tomography

PET/CT in oncology. Positron emission tomography Clinical Medicine 2012, Vol 12, No 4: 368 72 PET/CT in oncology Fahim-Ul-Hassan, SpR Nuclear Medicine, Guy s Hospital, London; Gary J Cook, professor of Clinical PET, KCL Division of Imaging Sciences &

More information

4D PET: promises and limitations

4D PET: promises and limitations 4D PET: promises and limitations Tinsu Pan, Ph.D. M.D. Anderson Cancer Center The University of Texas Background Outlines Gating techniques: Deep inspiration breath hold 4D PET/CT Non-gating techniques

More information

Nuclear Medicine in Thyroid Cancer. Phillip J. Koo, MD Division Chief of Diagnostic Imaging

Nuclear Medicine in Thyroid Cancer. Phillip J. Koo, MD Division Chief of Diagnostic Imaging Nuclear Medicine in Thyroid Cancer Phillip J. Koo, MD Division Chief of Diagnostic Imaging Financial Disclosures Bayer Janssen Learning Objectives To learn the advantages and disadvantages of SPECT/CT

More information

PET/MRI: a new era in multimodality molecular imaging

PET/MRI: a new era in multimodality molecular imaging Clin Transl Imaging (2013) 1:5 10 DOI 10.1007/s40336-013-0003-5 REVIEW ARTICLE PET/MRI: a new era in multimodality molecular imaging Osman Ratib Received: 22 October 2012 / Accepted: 10 January 2013 /

More information

FDG PET/CT STAGING OF LUNG CANCER. Dr Shakher Ramdave

FDG PET/CT STAGING OF LUNG CANCER. Dr Shakher Ramdave FDG PET/CT STAGING OF LUNG CANCER Dr Shakher Ramdave FDG PET/CT STAGING OF LUNG CANCER FDG PET/CT is used in all patients with lung cancer who are considered for curative treatment to exclude occult disease.

More information

Nuclear Medicine Head and Neck Region. Bán Zsuzsanna, MD University of Pécs, Department of Nuclear Medicine

Nuclear Medicine Head and Neck Region. Bán Zsuzsanna, MD University of Pécs, Department of Nuclear Medicine Nuclear Medicine Head and Neck Region Bán Zsuzsanna, MD University of Pécs, Department of Nuclear Medicine Thyroid scintigraphy Parathyroid scintigraphy F18-FDG PET examinations in head and neck cancer

More information

MR Tumor Staging for Treatment Decision in Case of Wilms Tumor

MR Tumor Staging for Treatment Decision in Case of Wilms Tumor MR Tumor Staging for Treatment Decision in Case of Wilms Tumor G. Schneider, M.D., Ph.D.; P. Fries, M.D. Dept. of Diagnostic and Interventional Radiology, Saarland University Hospital, Homburg/Saar, Germany

More information

Assessment of renal cell carcinoma by two PET tracer : dual-time-point C-11 methionine and F-18 fluorodeoxyglucose

Assessment of renal cell carcinoma by two PET tracer : dual-time-point C-11 methionine and F-18 fluorodeoxyglucose Assessment of renal cell carcinoma by two PET tracer : dual-time-point C-11 methionine and F-18 fluorodeoxyglucose Poster No.: C-0805 Congress: ECR 2015 Type: Scientific Exhibit Authors: S. Ito, K. Kato,

More information

Short summary of published results of PET with fluoromethylcholine (18F) in prostate cancer

Short summary of published results of PET with fluoromethylcholine (18F) in prostate cancer Short summary of published results of PET with fluoromethylcholine (18F) in prostate cancer JN TALBOT and all the team of Service de Médecine Nucléaire Hôpital Tenon et Université Pierre et Marie Curie,

More information

Optimized PET/CT protocols: how much CT is needed? Increasing use of PET-CT. Imaging in Lymphoma

Optimized PET/CT protocols: how much CT is needed? Increasing use of PET-CT. Imaging in Lymphoma BVS/ABR Workshop 2011 on dose related to multimodality imaging Optimized PET/CT protocols: how much CT is needed? 2008 Mean medical radiation exposure/head Belgium= 2.42 msv The Netherlands= 0.8 msv Belgium

More information

Theranostics in Nuclear Medicine

Theranostics in Nuclear Medicine Theranostics in Nuclear Medicine Patrick FLAMEN, MD, PhD Head Nuclear Medicine Institut Jules Bordet Université Libre de Bruxelles (U.L.B.) n Theranostics in Nuclear Medicine n A form of (nuclear) diagnostic

More information

Prof. Dr. NAGUI M. ABDELWAHAB,M.D.; MARYSE Y. AWADALLAH, M.D. AYA M. BASSAM, Ms.C.

Prof. Dr. NAGUI M. ABDELWAHAB,M.D.; MARYSE Y. AWADALLAH, M.D. AYA M. BASSAM, Ms.C. Role of Whole-body Diffusion MR in Detection of Metastatic lesions Prof. Dr. NAGUI M. ABDELWAHAB,M.D.; MARYSE Y. AWADALLAH, M.D. AYA M. BASSAM, Ms.C. Cancer is a potentially life-threatening disease,

More information

A Snapshot on Nuclear Cardiac Imaging

A Snapshot on Nuclear Cardiac Imaging Editorial A Snapshot on Nuclear Cardiac Imaging Khalil, M. Department of Physics, Faculty of Science, Helwan University. There is no doubt that nuclear medicine scanning devices are essential tool in the

More information

CT Optimisation for Paediatric SPECT/CT Examinations. Sarah Bell

CT Optimisation for Paediatric SPECT/CT Examinations. Sarah Bell CT Optimisation for Paediatric SPECT/CT Examinations Sarah Bell Sarah.bell14@nhs.net Outline 1. Introduction 2. Aims and Objectives 3. Methods 4. Results 5. Discussion 6. Conclusions 7. References Introduction

More information

Hybrid Imaging SPECT/CT PET/CT PET/MRI. SNMMI Southwest Chapter Aaron C. Jessop, MD

Hybrid Imaging SPECT/CT PET/CT PET/MRI. SNMMI Southwest Chapter Aaron C. Jessop, MD Hybrid Imaging SPECT/CT PET/CT PET/MRI SNMMI Southwest Chapter 2014 Aaron C. Jessop, MD Assistant Professor, Department of Nuclear Medicine UT MD Anderson Cancer Center, Houston, Texas Complimentary role

More information

PROGRAMME OVERVIEW Saturday, October 13, 2018

PROGRAMME OVERVIEW Saturday, October 13, 2018 Saturday, October 13, 2018 Plenary Hall Meeting Room 26 Hall 1 Hall 2 Hall 3 Hall X Hall Y Hall 28 - - - - - - - - - - Advisory Council Meeting Delegates Assembly 1 Radiopharmacy/ Drug Development Trial

More information

Integrated PET/CT systems State of the art and Clinical Applications

Integrated PET/CT systems State of the art and Clinical Applications Integrated PET/CT systems State of the art and Clinical Applications V. Bettinardi Nuclear Medicine Dep. Scientific Institute San Raffaele Hospital Milan Italy The announcement of a new Diagnostic Imaging

More information

Understanding the Diagnostic and Prognostic Role of Imaging in the Evaluation of an Anterior Mediastinal Mass

Understanding the Diagnostic and Prognostic Role of Imaging in the Evaluation of an Anterior Mediastinal Mass Understanding the Diagnostic and Prognostic Role of Imaging in the Evaluation of an Anterior Mediastinal Mass Daniel W. Kim, Harvard Medical School Year III Agenda Mediastinum Menu of tests Anatomy Normal

More information

General Nuclear Medicine

General Nuclear Medicine General Nuclear Medicine What is General Nuclear Medicine? What are some common uses of the procedure? How should I prepare? What does the equipment look like? How does the procedure work? How is the procedure

More information

Molecular Imaging Guided Therapy: The Perfect Storm. David M Schuster, MD Emory University Department of Radiology Atlanta, GA

Molecular Imaging Guided Therapy: The Perfect Storm. David M Schuster, MD Emory University Department of Radiology Atlanta, GA Molecular Imaging Guided Therapy: The Perfect Storm David M Schuster, MD Emory University Department of Radiology Atlanta, GA Talk can be found at radiology.emory.edu Let s start with a case 74 year

More information

New imaging techniques: let there be light. Felix M. Mottaghy Department of Nuclear Medicine University Hospital KU Leuven

New imaging techniques: let there be light. Felix M. Mottaghy Department of Nuclear Medicine University Hospital KU Leuven New imaging techniques: let there be light Felix M. Mottaghy Department of Nuclear Medicine University Hospital KU Leuven Medical imaging and the pathology cascade Molecular/Cellular disturbance Alterations

More information

F NaF PET/CT in the Evaluation of Skeletal Malignancy

F NaF PET/CT in the Evaluation of Skeletal Malignancy F NaF PET/CT in the Evaluation of Skeletal Malignancy Andrei Iagaru, MD September 26, 2013 School of of Medicine Ø Introduction Ø F NaF PET/CT in Primary Bone Cancers Ø F NaF PET/CT in Bone Metastases

More information

Imaging Pancreatic Neuroendocrine Tumors (PNETs): CT, MRI, EUS, Nuclear

Imaging Pancreatic Neuroendocrine Tumors (PNETs): CT, MRI, EUS, Nuclear Imaging Pancreatic Neuroendocrine Tumors (PNETs): CT, MRI, EUS, Nuclear Eric Tamm, M.D. Department of Diagnostic Radiology Division of Diagnostic Imaging MD Anderson Cancer Center Houston, TX Disclosure

More information

PET Imaging in Langerhans Cell Histiocytosis

PET Imaging in Langerhans Cell Histiocytosis PET Imaging in Langerhans Cell Histiocytosis Christiane Franzius Bremen, Germany Histiocytosis Histiocytosis Idiopathic proliferation of histiocytes Two types of histiocytes macrophages: antigen processing

More information

PET/CT in Breast Cancer

PET/CT in Breast Cancer PET/CT in Breast Cancer Rodolfo Núñez Miller, M.D. Nuclear Medicine and Diagnostic Imaging Section Division of Human Health International Atomic Energy Agency Vienna, Austria Overview Introduction Locorregional

More information

Positron Emission Tomography (PET) for Staging Low-Grade Non-Hodgkin s Lymphomas (NHL)

Positron Emission Tomography (PET) for Staging Low-Grade Non-Hodgkin s Lymphomas (NHL) CANCER BIOTHERAPY & RADIOPHARMACEUTICALS Volume 16, Number 4, 2001 Mary Ann Liebert, Inc. Positron Emission Tomography (PET) for Staging Low-Grade Non-Hodgkin s Lymphomas (NHL) F. Najjar, R. Hustinx, G.

More information

THE ROLE OF CONTEMPORARY IMAGING AND HYBRID METHODS IN THE DIAGNOSIS OF CUTANEOUS MALIGNANT MELANOMA(CMM) AND MERKEL CELL CARCINOMA (MCC)

THE ROLE OF CONTEMPORARY IMAGING AND HYBRID METHODS IN THE DIAGNOSIS OF CUTANEOUS MALIGNANT MELANOMA(CMM) AND MERKEL CELL CARCINOMA (MCC) THE ROLE OF CONTEMPORARY IMAGING AND HYBRID METHODS IN THE DIAGNOSIS OF CUTANEOUS MALIGNANT MELANOMA(CMM) AND MERKEL CELL CARCINOMA (MCC) I.Kostadinova, Sofia, Bulgaria CMM some clinical facts The incidence

More information

FDG-PET/CT for cancer management

FDG-PET/CT for cancer management 195 REVIEW FDG-PET/CT for cancer management Hideki Otsuka, Naomi Morita, Kyo Yamashita, and Hiromu Nishitani Department of Radiology, Institute of Health Biosciences, The University of Tokushima, Graduate

More information

The Use of PET Scanning in Urologic Oncology

The Use of PET Scanning in Urologic Oncology The Use of PET Scanning in Urologic Oncology Dr Nicholas C. Buchan Uro-oncology Fellow 1 2 Aims To understand the basic concepts underlying PET scanning. Understand the emerging role of PET Scanning for

More information

Table 1. Some other positron tracers with applications in oncology.

Table 1. Some other positron tracers with applications in oncology. CME: CLINICAL PRACTICE AND ITS BASIS Nuclear Medicine Edited by Peter J Ell FMedSci, University Chair and Director, Institute of Nuclear Medicine, UCL; Clinical Director, University College London Hospitals

More information

Understanding Biological Activity to Inform Drug Development

Understanding Biological Activity to Inform Drug Development National Cancer Policy Forum Understanding Biological Activity to Inform Drug Development December 12, 2016 Wolfgang Weber Molecular Imaging and Therapy Service Department of Radiology RECIST Response

More information

PET/MR. Are You Ready?? Derek Lee, BS, CNMT, PET

PET/MR. Are You Ready?? Derek Lee, BS, CNMT, PET PET/MR Are You Ready?? Derek Lee, BS, CNMT, PET Allow Myself to Introduce Myself I ve been around a while: 23+ years in Nuclear Medicine and counting PET & PET/CT for 13 years and counting Currently working

More information

Applications of PET in medicine and biomedical studies

Applications of PET in medicine and biomedical studies Lecture 21 Applications of PET in medicine and biomedical studies PET imaging is a technique for observing biological processes. Because disease is a biological process, molecular imaging is a sensitive

More information

Introduction. Methods and materials. 68 Ga-DOTATATE PET CT imaging in carotid body paragangliomas. Patients

Introduction. Methods and materials. 68 Ga-DOTATATE PET CT imaging in carotid body paragangliomas. Patients https://doi.org/10.1007/s12149-018-1242-3 SHORT COMMUNICATION 68 Ga-DOTATATE PET CT imaging in carotid body paragangliomas Duygu Has Şimşek 1 Yasemin Şanlı 2 Serkan Kuyumcu 2 Bora Başaran 3 Ayşe Mudun

More information

The Role of PET / CT in Lung Cancer Staging

The Role of PET / CT in Lung Cancer Staging July 2004 The Role of PET / CT in Lung Cancer Staging Vlad Vinarsky, Harvard Medical School Year IV Patient AM HPI: 81 yo F p/w hemoptysis x 1 month LLL lesion on CXR, not responsive to Abx 35 pack-year

More information

Using PET/CT in Prostate Cancer

Using PET/CT in Prostate Cancer Using PET/CT in Prostate Cancer Legal Disclaimer These materials were prepared in good faith by MITA as a service to the profession and are believed to be reliable based on current scientific literature.

More information

Typical PET Image. Elevated uptake of FDG (related to metabolism) Lung cancer example: But where exactly is it located?

Typical PET Image. Elevated uptake of FDG (related to metabolism) Lung cancer example: But where exactly is it located? Typical PET Image Elevated uptake of FDG (related to metabolism) Lung cancer example: But where exactly is it located? PET/CT Oncology Imaging Anatometabolic fusion images are useful in the management

More information

First Clinical Experience with

First Clinical Experience with First Clinical Experience with Discovery MI Digital PET/CT Martin Huellner Department of Nuclear Medicine University Hospital Zurich / University of Zurich Switzerland Agenda BelNuc GE Symposium 1. Digital

More information

Clinical indications for positron emission tomography

Clinical indications for positron emission tomography Clinical indications for positron emission tomography Oncology applications Brain and spinal cord Parotid Suspected tumour recurrence when anatomical imaging is difficult or equivocal and management will

More information

Positron emission tomography/computer tomography in the evaluation of head and neck cancer treatment

Positron emission tomography/computer tomography in the evaluation of head and neck cancer treatment Positron emission tomography/computer tomography in the evaluation of head and neck cancer treatment Severina Šedienė 1, Ilona Kulakienė 1, Viktoras Rudžianskas 2 1 Lithuanian University of Health Sciences,

More information

Testicular relapse of non-hodgkin Lymphoma noted on FDG-PET

Testicular relapse of non-hodgkin Lymphoma noted on FDG-PET Testicular relapse of non-hodgkin Lymphoma noted on FDG-PET Stephen D. Scotti 1*, Jennifer Laudadio 2 1. Department of Radiology, North Carolina Baptist Hospital, Winston-Salem, NC, USA 2. Department of

More information

New Visions in PET: Surgical Decision Making and PET/CT

New Visions in PET: Surgical Decision Making and PET/CT New Visions in PET: Surgical Decision Making and PET/CT Stanley J. Goldsmith, MD Director, Nuclear Medicine Professor, Radiology & Medicine New York Presbyterian Hospital- Weill Cornell Medical Center

More information

Lymphoma Read with the experts

Lymphoma Read with the experts Lymphoma Read with the experts Marc Seltzer, MD Associate Professor of Radiology Geisel School of Medicine at Dartmouth Director, PET-CT Course American College of Radiology Learning Objectives Recognize

More information

MRI in lymphoma: where are we in 2016

MRI in lymphoma: where are we in 2016 MRI in lymphoma: where are we in 2016 Alain Rahmouni Henri Mondor Academic Hospital Paris Est Créteil University, France Plan Requirements DWI signal in lymphoma ADC measurement SNR: Surface coils 1.5

More information

4th INTERNATIONAL WORKSHOP ON INTERIM-PET IN LYMPHOMA Palais de l Europe, Menton Oct 4-5, 2012

4th INTERNATIONAL WORKSHOP ON INTERIM-PET IN LYMPHOMA Palais de l Europe, Menton Oct 4-5, 2012 4th INTERNATIONAL WORKSHOP ON INTERIM-PET IN LYMPHOMA Palais de l Europe, Menton Oct 4-5, 2012 international workshop for PET in lymphoma staging and restaging Lale Kostakoglu Department of Radiology Mount

More information

performed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.

performed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management. Hello, I am Maura Polansky at the University of Texas MD Anderson Cancer Center. I am a Physician Assistant in the Department of Gastrointestinal Medical Oncology and the Program Director for Physician

More information

UK Musculoskeletal Oncology: Something for All Ages. Lars Wagner, MD Pediatric Hematology/Oncology University of Kentucky

UK Musculoskeletal Oncology: Something for All Ages. Lars Wagner, MD Pediatric Hematology/Oncology University of Kentucky UK Musculoskeletal Oncology: Something for All Ages Lars Wagner, MD Pediatric Hematology/Oncology University of Kentucky Pediatric-Type Sarcomas of Bone and Soft Tissue The incidence of sarcoma continues

More information

PET-MRI in Cardiac Imaging: Initial Experience

PET-MRI in Cardiac Imaging: Initial Experience PET-MRI in Cardiac Imaging: Initial Experience Mallinckrodt Institute of Radiology Washington University School of Medicine Pamela K. Woodard, M.D. Professor of Radiology and Biomedical Engineering Head,

More information

MEASUREMENT OF EFFECT SOLID TUMOR EXAMPLES

MEASUREMENT OF EFFECT SOLID TUMOR EXAMPLES MEASUREMENT OF EFFECT SOLID TUMOR EXAMPLES Although response is not the primary endpoint of this trial, subjects with measurable disease will be assessed by standard criteria. For the purposes of this

More information

Positron Emission Tomography in Lung Cancer

Positron Emission Tomography in Lung Cancer May 19, 2003 Positron Emission Tomography in Lung Cancer Andrew Wang, HMS III Patient DD 53 y/o gentleman presented with worsening dyspnea on exertion for the past two months 30 pack-year smoking Hx and

More information

The Importance of PET/CT in Human Health. Homer A. Macapinlac, M.D.

The Importance of PET/CT in Human Health. Homer A. Macapinlac, M.D. The Importance of PET/CT in Human Health Homer A. Macapinlac, M.D. Learning objectives Provide an overview of the impact of PET/CT imaging on the management of patients and its impact on health care expenditures.

More information

Jeffrey C. Weinreb, MD, FACR Yale School of Medicine Yale-New Haven Hospital

Jeffrey C. Weinreb, MD, FACR Yale School of Medicine Yale-New Haven Hospital Jeffrey C. Weinreb, MD, FACR Yale School of Medicine Yale-New Haven Hospital jeffrey.weinreb@yale.edu 1991 1997 Whole body MRI: multistation approach x z Isocenter: Table Move: Multiple Steps Whole body

More information

FDG PET/CT Versus I-131 MIBG Scan in Diagnosis of Neuroblastoma Osseous Infiltrates; Comparative Study

FDG PET/CT Versus I-131 MIBG Scan in Diagnosis of Neuroblastoma Osseous Infiltrates; Comparative Study Egyptian J. Nucl. Med., Vol. 10, No. 2, Dec 2014 85 Original article, Oncology FDG PET/CT Versus I-131 MIBG Scan in Diagnosis of Neuroblastoma Osseous Infiltrates; Comparative Study Amr, M 1. Kotb, M 1,

More information

Imaging: When to get MRI, CT or PET-CT?

Imaging: When to get MRI, CT or PET-CT? Imaging: When to get MRI, CT or PET-CT? Alina Uzelac, D.O. Assistant Clinical Professor Neuroradiology UCSF Department of Radiology and Biomedical Imaging San Francisco General Hospital Overview CT MRI

More information

objectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University

objectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University objectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University To determine the regions of physiologic activity To understand

More information